I am interested to find out the reason for the consistent price deline. One reason can be that nothing of essence will be announced in the coming months. The next expected news is the full Phase 3 data set at a medical meeting later this year and submit a rolling biologics license application to the FDA in the fourth quarter of 2020.
Funny, all 3 of my pivot portfolio stocks: GMDA, BVXV and BCLI are to come to a crescendo by 2020 year end!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.